Pharmacists in Exeter, New Hampshire


13 Pharmacists found in Exeter
male pharmacist

Colin Morrison, PHARMD


Pharmacist
141 Portsmouth Ave, Exeter, NH 03833
603-772-6252    

female pharmacist

Emily Jalbert, PHARMD


Pharmacist
75 Portsmouth Ave Unit A, Exeter, NH 03833
603-778-0553    

male pharmacist

Dr. Eric J Hoynack, PHARM.D.


Pharmacist
48 Portsmouth Ave, Exeter, NH 03833
603-772-3551    



female pharmacist

Erum Rizvi, B.S(PHARM)


Pharmacist
69 Portsmouth Ave, Exeter, NH 03833
603-778-0553     603-778-2587

female pharmacist

Heather Ann Hatem, PHARMD


Pharmacist
141 Portsmouth Ave, Exeter, NH 03833
603-772-6252    

male pharmacist

James Robert Vivenzio, PHARMACIST


Pharmacist
69 Portsmouth Ave, Exeter, NH 03833
603-778-0553     603-778-2587

female pharmacist

Mrs. Julie T Cotreau, PHARMD, PIC, CIP


Pharmacist
75 Portsmouth Ave, Exeter, Exeter, NH 03833
603-778-0553     603-778-2587

female pharmacist

Kathleen E Colgan, RPH.


Pharmacist
75 Portsmouth Ave, Exeter, NH 03833
603-778-0553    

male pharmacist

Mohmedshad Shaikh, PHARMD


Pharmacist
75 Portsmouth Ave Ste 1, Exeter, NH 03833
603-778-0553    

male pharmacist

Richard Garcia, RPH


Pharmacist
49 Portsmouth Ave, Exeter, NH 03833
603-772-3551    

male pharmacist

Mr. Robert P Berman, RPH


Pharmacist
48 Portsmouth Ave, Exeter, NH 03833
603-772-3551    

male pharmacist

Mr. Walter Kelter, RPH


Pharmacist
48 Portsmouth Ave, Exeter, NH 03833
603-772-3551     603-773-9968

female pharmacist

Dr. Yolanda Marisa Tonelli, PHARM.D.


Pharmacist
48 Portsmouth Ave Ste A, Exeter, NH 03833
603-772-3551     603-773-9968


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.